Launching the EASL Guidelines App!
Introducing the EASL Guidelines App – your indispensable mobile companion for accessing comprehensive and up-to-date clinical practice guidelines in hepatology. Developed by EASL, the European Association for the Study of the Liver,…
GENIAL: A pioneering initiative for early diagnosis of alcohol-related hepatocellular carcinoma
The GENIAL project is dedicated to enhancing our understanding of the early stages of alcohol-related hepatocellular carcinoma (ALD-HCC) by integrating clinical hepatology expertise with artificial intelligence (AI). This innovative initiative, as explained…
THRIVE related activities at EASL Congress 2024
THRIVE is an EU-founded initiative that brings together a strong and multidisciplinary team with 13 partners, from 8 countries, with complementary expertise in liver cancer research and in the use of cutting-edge…
GENIAL related activities at EASL Congress 2024
GENIAL is a pioneering initiative targeting alcohol-related liver cancer (ALD-HCC). Our primary goal is to identify genetic and environmental factors contributing to ALD-HCC risk and unravel how their interactions drive alcohol-related liver…
LIVERAIM related activities at EASL Congress 2024
The LIVERAIM project’s overall goal is to set up a screening platform to detect cases of liver disease early on, so that patients can take steps to protect their liver before it’s…
MICROB-PREDICT related activities at EASL Congress 2024
22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease (cirrhosis). We aim to identify microbiome-based biomarkers and mechanisms that predict in advance when the…
A-TANGO related activities at EASL Congress 2024
A-TANGO strives to increase the survival rate with G-TAK – a novel combinatorial therapy, and to decrease the burden on the national healthcare systems, which is caused by a large percentage of patients…